
Now, at a time when there is much discussion about mankind being directly responsible for the rise in the emission of greenhouse gases, methane emission levels already far outstrip carbon dioxide. Methane (CH 4) and carbon dioxide (CO 2) both cause global warming, although the impact of methane is 25 times more powerful than the one of carbon dioxide on a timescale of 100 years. The primary objective is to obtain spatial and temporal gradients of atmospheric methane (CH 4) columns with high precision and unprecedented accuracy on a global scale. MERLIN is a Franco-German collaborative minisatellite climate mission. Spacecraft Launch Sensor Complement Ground Segment References MERLIN is continuing the development of its products and processes, taking into account sustainability as well as environmental and economic aspects, with the aim of implementing the Antibiotic Stewardship for the rational use of the anti-infectives.MERLIN (Methane Remote Sensing Lidar Mission) Minisatellite "These are core competencies that make a decisive contribution to the successful implementation of the joint research project," emphasizes Dr. MERLIN also has a great expertise in the handling of antimicrobial agents, which are meaningful in the validation of the manufacture, packaging, storage and application of antibiotic-containing diagnostics. These systems are supplemented by phenotypic detection methods for the detection of clinically and epidemiologically relevant resistance mechanisms. MERLIN's diagnostic systems for quantitative susceptibility testing allow the determination of the minimum inhibitory concentration (MIC value) in accordance with the normative requirements. MERLIN has already made essential preparations for this project because we are specialized in the development, validation and marketing of various microbiological diagnostic systems for the qualitative and quantitative detection of microbial antibiotic resistance. With this an infection can be treated very early in the process and very specifically. PathoSept is intended to open up the reliable diagnosis after nine hours, thus significantly reducing the high mortality rate, but above all the new generation and spread of multiresistant pathogens, as well as the intensive medical costs. Currently, the time between suspected diagnosis and targeted therapy can last up to five days, and infections with multiresistant pathogens can not be adequately treated. The volume of this project is about 3.5 million euros.Įvery year, more than 56,000 people die from sepsis in Germany, one of the most severe bacterial infections that can be even simply caused by a purulent tooth. In addition to the Fraunhofer Institute and MERLIN, the companies Carpegen GmbH, based in Münster, and Jüke Systemtechnik GmbH as well as the university clinics of Aachen and Bonn, belong to the network. Esther Pfeil, Managing Director of MERLIN Diagnostika.



Based on these results, it can be initiated a targeted individual antibiotic therapy no later than nine hours", says Dr. It very quickly identifies pathogenic agents of life-threatening infections and simultaneously allows a quantitative determination of the antibiotic resistance profile. "Winner is also our project 'PathoSept', with which we want to create a diagnostic complete system under the coordination of the Fraunhofer Institute for Applied Information Technology. In the key market competition LifeSciences.NRW, 10 joint projects were selected from 51 contest entries, which will be funded with a total of 19.3 million euros. | MERLIN Diagnostika is one of the winners of the first round in the key market competition LifeSciences.NRW: Referees voted for the joint research project "PathoSept", which is intended to save many lives by rapidly diagnosing threatening infections.
